CAPTRUST FINANCIAL ADVISORS - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$9,100
-32.1%
20,0000.0%0.00%
Q2 2023$13,400
+55.8%
20,0000.0%0.00%
Q1 2023$8,600
-28.3%
20,0000.0%0.00%
Q3 2022$12,000
-25.0%
20,0000.0%0.00%
Q2 2022$16,000
-23.8%
20,0000.0%0.00%
Q1 2022$21,000
+16.7%
20,0000.0%0.00%
Q4 2021$18,000
-55.0%
20,0000.0%0.00%
Q3 2021$40,000
-7.0%
20,0000.0%0.00%
Q2 2021$43,000
+34.4%
20,000
+42.9%
0.00%
Q1 2021$32,000
+77.8%
14,000
+40.0%
0.00%
Q4 2020$18,00010,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$9,1000.00%
D.B. Root & Company, LLC 12,050$5,4830.00%
SeaCrest Wealth Management, LLC 37,063$16,8640.00%
SNS Financial Group, LLC 10,000$4,5500.00%
Virtu Financial LLC 29,061$130.00%
VisionPoint Advisory Group, LLC 3,142$1,4300.00%
Community Bank, N.A. 13,226$5,9510.00%
Verition Fund Management LLC 148,000$67,3400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$49,5500.00%
Traynor Capital Management, Inc. 11,777$5,3590.00%
View complete list of AIM IMMUNOTECH INC shareholders